Lupin launches generic Femhrt
BALTIMORE — Lupin announced this week that it had launched its Fyavolv tablets, a generic of Femhrt (norethindrone acetate and ethinyl estradiol). The drug is indicated to treat moderate to severe menopause-related vasomotor symptoms and to prevent postmenopausal osteoporosis.
The drug had U.S. sales of about $39 million for the 12 months ended December 2015, according to IMS Health.